By Jeff Wheelwright | Discover
When a cancer patient has run out of options—when her disease has returned and the latest experimental drug has failed and her oncologist hasn’t much to say—that’s when the patient would be fortunate to meet Tracy Balboni. She’s a radiation oncologist and palliative care researcher at Harvard Medical School and Dana-Farber Cancer Institute in Boston. She works at the murky stage of care known as end-of-life, where decisions . . .
